Overview
- The court ruled in United States v. Skrmetti that prohibiting puberty blockers and hormone therapy for transgender minors falls under rational basis review
- Chief Justice John Roberts wrote that the Equal Protection Clause cannot resolve disputed scientific and policy questions about gender-affirming treatments
- Justice Sonia Sotomayor dissented by stating the majority “abandons transgender children and their families to political whims”
- The decision sets a precedent for at least 26 states with similar bans and is likely to keep those laws intact
- Major medical organizations, including the American Medical Association and the American Academy of Pediatrics, criticized the ruling as a setback for transgender healthcare access